"Faith is taking the first step even when you don't see the whole staircase." ✍️ - Martin Luther King Jr. |
✅ U.S. equity markets finished modestly lower on Friday. Gains in real estate and industrial stocks were offset by weakness in the health care sector. ✅ Trump threatened tariffs up to 25% on imports from eight European allies if Greenland is not sold to the U.S., sparking EU condemnation. ✅ Elon Musk is seeking $134 billion from OpenAI and Microsoft, claiming “wrongful gains” from his early contributions, which the companies reject. ✅ Trump plans to sue JPMorgan over alleged “debanking” after Jan. 6, criticizing CEO Jamie Dimon and alleging political discrimination. ✅ Nvidia suppliers halted H200 chip production after China blocked shipments, threatening planned Chinese orders. ✅ Saudi FDA approved ImmunityBio’s ANKTIVA® for bladder cancer, expanding global access and supporting ongoing clinical trials. |
↘ Dow 49,359.33 - 0.17%
↘ Nasdaq 23,515.39 - 0.062%
↘ S&P 6,940.01 - 0.064% |
Trump Threatens Tariffs on Eight European Nations Over Greenland |
Image courtesy of Andrew Caballero-Reynolds/AFP via Getty Images |
President Donald Trump said Saturday that the United States will impose escalating tariffs on imports from eight European NATO allies unless Greenland is sold to the U.S. In a post on Truth Social, Trump said tariffs on goods from Denmark, Norway, Sweden, France, Germany, the United Kingdom, the Netherlands, and Finland will begin at 10% on Feb. 1 and rise to 25% by June 1 if a deal is not reached. The new duties would be added to existing U.S. tariffs already in place on imports from those countries. Trump suggested the move was prompted by recent troop deployments to Greenland by several European nations, calling the situation “very dangerous” for global security. He reiterated that U.S. control of Greenland is necessary for national security and hinted the tariff strategy could mirror past efforts to pressure foreign governments through trade measures. The announcement has heightened tensions with the European Union, where tariffs applied to any member state would extend to the entire 27-nation bloc. The threat also jeopardizes a U.S.–EU trade agreement reached in August. Senior EU officials said approval of the deal is now unlikely under the current circumstances. EU ambassadors are scheduled to hold an emergency meeting on Sunday to discuss a coordinated response. European leaders broadly condemned the tariff threat, characterizing it as an attack on close allies and a challenge to the trans-Atlantic partnership. European Commission President Ursula von der Leyen rejected the ultimatum, emphasizing cooperation over confrontation. Denmark’s prime minister said the troop movements were defensive and coordinated transparently with allies, while leaders from France, Sweden, and other countries warned they would not be pressured through economic coercion. EU foreign policy chief Kaja Kallas cautioned that the dispute risks benefiting geopolitical rivals, urging that any security concerns related to Greenland be addressed within NATO rather than through unilateral trade action. |
Musk Seeks Up To $134 Billion From OpenAI and Microsoft in ‘Wrongful Gains’ |
Image courtesy of siasat.com |
Elon Musk is seeking up to $134 billion from OpenAI and Microsoft, arguing that he is entitled to “wrongful gains” the companies allegedly earned from his early involvement, according to a court filing submitted Friday. Musk claims OpenAI generated between $65.5 billion and $109.4 billion in value from his contributions when he helped co-found the organization in 2015, while Microsoft gained between $13.3 billion and $25.1 billion. The filing comes ahead of a jury trial between Musk and the two companies. “Without Elon Musk, there would be no OpenAI,” said Musk’s lead trial lawyer, Steven Molo, in a statement to Reuters, citing Musk’s seed funding, reputation, and guidance on scaling the business. OpenAI rejected the claim, calling it an “unserious demand” and part of what it described as a broader harassment campaign by Musk. Microsoft declined to comment outside regular business hours. Earlier this week, OpenAI characterized Musk’s lawsuit as “baseless,” while a Microsoft attorney said there is no evidence the company aided or abetted any alleged misconduct. Both companies also filed a separate motion Friday challenging Musk’s damages claims. Musk, who left OpenAI in 2018 and now leads xAI, a competitor to ChatGPT, alleges that OpenAI violated its founding mission by restructuring into a for-profit entity. A federal judge in Oakland, California, ruled earlier this month that the case will proceed to a jury trial, currently expected to begin in April. According to the filing, Musk contributed roughly $38 million—about 60% of OpenAI’s initial seed funding—and played a key role in recruiting staff, connecting founders with industry contacts, and lending credibility to the venture. Musk argues that, like early startup investors, he is entitled to gains far exceeding his original investment. Musk’s damages calculations were prepared by expert witness C. Paul Wazzan, a financial economist. The filing also notes that Musk may seek punitive damages and other penalties, including a possible injunction, should the jury find either company liable. OpenAI and Microsoft, however, urged the court to limit Wazzan’s testimony, arguing that his analysis is “unverifiable,” “unprecedented,” and could mislead jurors. They also disputed Musk’s damages estimates more broadly, calling the methodology unreliable and implausible. |
Trump Blasts Dimon, Threatens Lawsuit Against JPMorgan Over ‘Debanking’ |
Image courtesy of theforage.com |
President Donald Trump criticized JPMorgan Chase & Co. and its chief executive, Jamie Dimon, on Saturday, threatening to sue the bank over his claim that he was improperly “debanked” following the Jan. 6, 2021, Capitol riot. Trump’s remarks came in response to a Wall Street Journal report suggesting he had previously floated Dimon as a potential Federal Reserve chair—a claim Trump dismissed. In a post on social media, Trump said no such offer was ever made and added that he plans to file a lawsuit against JPMorgan within the next two weeks for what he described as the bank’s “incorrect and inappropriate” closure of his accounts. Trump has previously alleged that JPMorgan discriminated against him by asking him to close accounts he had held for decades, an action he believes was politically motivated in the aftermath of Jan. 6. JPMorgan has said it opposes political or religious discrimination in banking and supports efforts to address concerns over so-called debanking, noting it is subject to ongoing regulatory reviews and legal proceedings related to the issue. JPMorgan spokesperson Trish Wexler reiterated that the bank does not close accounts based on political or religious beliefs and welcomed recent efforts by the administration to address the matter. Dimon said earlier this week that he would not consider serving as Federal Reserve chair under any circumstances, though he indicated he would be open to discussions about leading the Treasury Department. In a separate statement, Dimon said no job offers had been made and praised Treasury Secretary Scott Bessent’s performance. Trump has not yet named a successor to Federal Reserve Chair Jerome Powell, whose term as chair expires in May. He said Friday that he has a candidate in mind but declined to identify the individual. The dispute comes amid renewed public tension between Trump and Dimon over the president’s criticism of the Federal Reserve, including recent Justice Department subpoenas related to renovations at the Fed’s headquarters. Dimon has warned that undermining the central bank’s independence could lead to higher inflation and interest rates over time. |
Nvidia Suppliers Halt H200 Production After China Blocks Chip Shipments |
Image courtesy of Reuters |
Suppliers of key components for Nvidia’s H200 AI chips have paused production after Chinese customs authorities blocked shipments from entering China. The H200 chip had recently received U.S. approval for sale in China, prompting Nvidia to ramp up production in anticipation of strong demand. Chinese customs officials this week instructed logistics firms in Shenzhen not to submit clearance applications for H200 shipments, though it remains unclear whether the move is temporary. A sustained ban would deal a significant blow to Nvidia, which had expected orders of more than one million units from Chinese customers, with initial deliveries planned as early as March. Regulatory uncertainty led suppliers to halt output to avoid inventory losses, particularly for components such as printed circuit boards that are custom-designed for the H200 and cannot be repurposed. The development reflects China’s broader push to prioritize domestically produced chips, as regulators continue to debate whether and how to allow limited access to advanced foreign AI processors. |
Saudi FDA Grants Accelerated Approval to ImmunityBio’s ANKTIVA® for Non-Muscle-Invasive Bladder Cancer |
Image courtesy of gaurology.com |
The Saudi Food and Drug Authority (SFDA) has granted accelerated approval for ANKTIVA® (nogapendekin alfa inbakicept) plus BCG to treat adult patients with BCG-unresponsive non-muscle-invasive bladder cancer (NMIBC) with carcinoma in situ, with or without papillary disease. This approval adds to existing authorizations in the U.S. and U.K., as well as conditional approval in the European Union, reflecting ImmunityBio’s goal of providing bladder surgery-sparing options globally. Enrollment in the randomized QUILT-2.005 trial for BCG-naïve NMIBC patients is ahead of schedule, with full enrollment expected by Q2 2026 and potential BLA submission targeted for year-end. ImmunityBio plans to open a regional office in Saudi Arabia and partner with BioPharma Cigalah to support physicians, expand access across the Middle East and North Africa, and address the region’s growing unmet need for innovative cancer treatments. About ANKTIVA®: ANKTIVA® is a first-in-class IL-15 agonist that activates NK cells and restores memory CD8+ T cell activity, enhancing immune response against resistant tumor cells and prolonging complete response duration. It is a key component of ImmunityBio’s BioShield platform. ImmunityBio (IBRX) continued to climb on Friday after surging over 30% on Thursday, following the release of strong guidance for its bladder cancer treatment. |
📉 ON THE MOVE AND NOTABLES 📈 |
✔️ There was a heavy dose of economic data for investors to digest this week, highlighted by the monthly inflation and retail sales data. Both the headline month-over-month (MoM) and year-over-year (YoY) figures were in-line with estimates (+0.3% and +2.7%, respectively), but both the core figures came in 0.1% below expectations (+0.2% and +2.6%, respectively). ✔️ Retail sales for November came in above estimates (0.6% vs. +0.4% expected), as did the ex-autos figure (+0.5% vs. +0.3% expected). ✔️ Bond yields moved higher, with the 10-year U.S. Treasury yield ending the day at 4.23%. ✔️ Overseas, Asian markets closed higher after the announcement of a Taiwan–U.S. trade agreement that would reduce tariffs on Taiwanese imports to 15% from 20%, in exchange for a $250 billion investment in U.S. semiconductor manufacturing capacity. ✔️ European markets declined following President Trump’s proposal to impose new tariffs on countries opposing U.S. control of Greenland. ✔️ The U.S. dollar strengthened against major currencies. ✔️ Crude oil futures fell more than 4% as traders reassessed the likelihood of a U.S. military strike on Iran following comments from President Donald Trump. ✔️ Silver futures rose more than 1% to a record high, while gold futures slipped less than 1% from their own record levels. ✔️ Bitcoin futures declined more than 1% on Thursday, pulling back from a two-month high after the Senate Banking Committee delayed a vote on a key market-structure bill. Bitcoin edged slightly higher early Friday and marked its third straight weekly gain for the first time since July. ✔️ Fourth-quarter earnings season began this week, led by the major U.S. banks. JPMorgan Chase, Bank of America, Wells Fargo, Goldman Sachs, and Morgan Stanley all reported results that exceeded analysts’ expectations. ✔️ Overall, S&P 500 earnings are expected to grow approximately 8.0% year over year in the fourth quarter, with the technology sector leading the way at more than 25% growth. ✔️ Treasury yields rose modestly, with the 10-year yield closing at 4.23%. The benchmark yield has remained largely range-bound between 4.0% and 4.25% in recent months. ✔️ Micron Technology (MU) jumped after a board member disclosed the purchase of almost $8 million worth of company shares. ✔️ PNC Financial (PNC) advanced after reporting earnings that exceeded expectations. The bank said fourth-quarter profit rose 25%, driven by higher interest income and dealmaking activity, and projected 11% revenue growth in 2026, above consensus forecasts. ✔️ Shares of J.B. Hunt (JBHT) fell after the logistics company reported lower quarterly revenue, citing weaker transcontinental load volumes. ✔️ Coupang (CPNG) gained after Deutsche Bank upgraded the stock to Buy, noting that much of the regulatory uncertainty facing the Korean e-commerce retailer appears to be priced in. |
💲What to Watch Next Week💲 |
Economic: 🟢 Monday (Jan. 19): -no reports- 🟢 Tuesday (Jan. 20): -no reports- 🟢 Wednesday (Jan. 21): Building Permits, Construction Spending, Housing Starts, MBA Mortgage Applications Index, Pending Home Sales 🟢 Thursday (Jan. 22): Continuing Claims, EIA Crude Oil Inventories, EIA Natural Gas Inventories, Q3 GDP – Revised (3rd estimate), Initial Claims, PCE Prices, Personal Income, Personal Spending 🟢 Friday (Jan. 23): University of Michigan Consumer Sentiment - Final
Earnings: 🟢 Monday (Jan. 19): -no reports- 🟢 Tuesday (Jan. 20): D.R. Horton Inc. (DHI), Fastenal Co. (FAST), Fifth Third Bancorp (FITB), KeyCorp (KEY), Interactive Brokers Group Inc. (IBKR), Netflix Inc. (NFLX), 3M Co. (MMM), United Airlines (UAL), US Bancorp (USB), Zions Bancorporation (ZION) 🟢 Wednesday (Jan. 21): CACI International Inc. (CACI), Charles Schwab Corp. (SCHW), Halliburton Co. (HAL), Johnson & Johnson (JNJ), Kinder Morgan Inc. (KMI), Knight-Swift Transportation Holdings (KNX), Pinnacle Financial Partners Inc. (PNFP), Prologis Inc. (PLD), Rli Corp. (RLI), TE Connectivity PLC (TEL), Travelers Companies Inc. (TRV), Truist Financial Corp. (TFC) 🟢 Thursday (Jan. 22): Abbott Laboratories (ABT), Alcoa Corp. (AA), Capital One Financial Corp. (COF), CSX Corp. (CSX), East West Bancorp (EWBC), Freeport-McMoRan Inc. (FCX), GE Aerospace (GE), Huntington Bancshares (HBAN), Intel Corp. (INTC), Intuitive Surgical Inc. (ISRG), McCormick & Company (MCK), Procter & Gamble Co. (PG) 🟢 Friday (Jan. 23): Booz Allen Hamilton Holding Corp. (BAH), Comerica Inc. (CMA), First Citizens BancShares (FCNCA), SLB NV (SLB), Webster Financial Corp. (WBS) |
Watch Our Latest Weekly Video On Youtube Or Spotify " Iran Tensions Shake Markets" |
|
|
Disclaimer: We are engaged in the business of advertising and promoting companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. Neither the owner of Bullish Bear nor any of its members, officers, directors, contractors or employees are licensed broker-dealers, account representatives, market makers, investment bankers, investment advisers, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed on Bullish Bear. It is possible that a viewer's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed on this website unless you can afford to lose your entire investment. Also, investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. Bullish Bear makes no recommendation that the securities of the companies profiled or discussed on this website should be purchased, sold or held by viewers that learn of the profiled companies through our website.
Some of the content on this website contains "forward-looking statements." Such statements may be preceded by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential," or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which may be beyond a company’s control, and cannot be predicted or quantified, and, consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. It is hereby noted that forward-looking statements contained herein may include everything other than historical information, involve risk and uncertainties that may affect a company's actual results of operation. A company's actual performance could greatly differ from those described in any forward-looking statements or announcements mentioned on this website or the websites contained within. Factors that should be considered that could cause actual results to differ include: the size and growth of the market for the company's products; the company's ability to fund its capital requirements in the near term and in the long term; pricing pressures; unforeseen and/or unexpected circumstances in happenings; etc. and the risk factors and other factors set forth in the company's filings with the Securities and Exchange Commission. However, a company's past performance does not guarantee future results.
Generally, the information regarding a company profiled or discussed on this website is provided from public sources bullishbear.com makes no representations, warranties or guarantees as to the accuracy or completeness of the information provided or discussed. Viewers should not rely solely on the information obtained through our website or in communications originating from our website. Viewers should use the information provided by us regarding the profiled companies as a starting point for additional independent research on the companies profiled or discussed in order to allow the viewer to form his or her own opinion regarding investing in the securities of such companies. Factual statements, or the similar, made by the profiled companies are made as of the date stated and are subject to change without notice and Bullish Bear has no obligation to update any of the information provided. Bullish Bear, its owners, officers, directors, contractors and employees are not responsible for errors and omissions.
From time to time certain content on this website is written and published by our employees or third parties. In addition to information about our profiled companies, from time to time, our website will contain the symbols of companies and/or news feeds about companies that are not being profiled by us but are merely illustrative of certain activity in the micro cap or penny stock market that we are highlighting. Viewers are advised that all analysis reports and news feeds are issued solely for informational purposes. Any opinions expressed are subject to change without notice. It is also possible that one or more of the companies discussed or profiled on this website may not have approved certain or any statements within the website. Bullish Bear encourages viewers to supplement the information obtained from this website with independent research and other professional advice. The content on this website is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Third Party Web Sites and Other Information This website may provide hyperlinks to third party websites or access to third party content. Bullish Bear, its owners, officers, directors, contractors and employees are not responsible for errors and omissions nor does Bullish Bear control, endorse, or guarantee any content found in such sites. Bullish Bear does not control, endorse, or guarantee content found in such sites. By accessing, viewing, or using the website or communications originating from the website, you agree that Bullish Bear, its owners, officers, directors, contractors and employees, are not responsible for any content, associated links, resources, or services associated with a third party website. You further agree that Bullish Bear, its owners, officers, directors, contractors and employees shall not be liable for any loss or damage of any sort associated with your use of third party content. Links and access to these sites are provided for your convenience only. Bullish Bear uses third parties to disseminate information to subscribers. Although we take precautions to prevent others from obtaining our subscriber list, there is a risk that our subscriber list, through no wrong doing on our part, could end up in the hands of an unauthorized party and that subscribers will receive communications from unauthorized third parties. We encourage viewers to invest carefully and read the investor issuer information available at the web sites of the United States Securities and Exchange Commission (SEC). The SEC has launched an investor-focused website to help you invest wisely and avoid fraud at www.investor.gov and filings made by public companies can be viewed at www.sec.gov and/or the Financial Industry Regulatory Authority (FINRA) at: www.finra.org. In addition, FINRA has published information at its website on how to invest carefully at www.finra.org/Investors/index.htm. |
|
|
Manage your preferences | Opt Out using TrueRemove™
Got this as a forward? Sign up to receive our future emails.
View this email online. |
502 E Atlantic Ave 232 | Delray Beach, None 33483 US |
|
|
This email was sent to punjabsvera@gmail.com.
To continue receiving our emails, add us to your address book. |
|
|
|
